532989 Stock Overview
Manufactures and sells finished pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Bafna Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹81.00 |
| 52 Week High | ₹112.20 |
| 52 Week Low | ₹73.35 |
| Beta | 0.46 |
| 11 Month Change | 0.074% |
| 3 Month Change | -1.22% |
| 1 Year Change | -7.95% |
| 33 Year Change | -31.24% |
| 5 Year Change | n/a |
| Change since IPO | 1,442.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532989 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.2% | 1.1% | 2.0% |
| 1Y | -8.0% | 43.3% | 28.6% |
Return vs Industry: 532989 underperformed the Indian Pharmaceuticals industry which returned 43.8% over the past year.
Return vs Market: 532989 underperformed the Indian Market which returned 29.5% over the past year.
Price Volatility
| 532989 volatility | |
|---|---|
| 532989 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532989 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532989's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 363 | Bansilal Mahaveer Bafna | www.bafnapharma.com |
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India.
Bafna Pharmaceuticals Limited Fundamentals Summary
| 532989 fundamental statistics | |
|---|---|
| Market cap | ₹1.85b |
| Earnings (TTM) | ₹4.07m |
| Revenue (TTM) | ₹1.43b |
454.8x
P/E Ratio1.3x
P/S RatioIs 532989 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532989 income statement (TTM) | |
|---|---|
| Revenue | ₹1.43b |
| Cost of Revenue | ₹1.05b |
| Gross Profit | ₹387.24m |
| Other Expenses | ₹383.17m |
| Earnings | ₹4.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 26.99% |
| Net Profit Margin | 0.28% |
| Debt/Equity Ratio | 22.7% |
How did 532989 perform over the long term?
See historical performance and comparison